Lipid peroxidation, leukocyte function and apoptosis in hemodialysis patients treated with vitamin E-modified filters

Contributions to Nephrology

Volumn 127, Issue , 1999, Pages 156-171

  Galli, F ^a   Rovidati, S ^a   Benedetti, S ^a   Canestrari, F ^a   Ferraro, B ^a   Floridi, A ^b   Buoncristiani, U ^c  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Ospedale Silvestrini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT;

ANIMAL; APOPTOSIS; ARTICLE; FILTRATION; HUMAN; LEUKOCYTE; LIPID PEROXIDATION; PHYSIOLOGY; RAT; RENAL REPLACEMENT THERAPY; RESPIRATORY BURST;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; FILTRATION; HUMANS; LEUKOCYTES; LIPID PEROXIDATION; RATS; RENAL DIALYSIS; RESPIRATORY BURST; VITAMIN E;

EID: 0033251185     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059998     Document Type: Article

References (46)

1. Lougherey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER: Oxidative stress in haemodialysis. Q J Med 1994;87:679-683.
2. Hasselwander O, Young IS: Oxidative stress in chronic renal failure. Free Radic Res 1998;29:1-11.
3. Galli F, Bellomo G: Physiopathology of oxidative stress and its implication in hemodialysis patients. Contrib Nephrol. Basel, Karger, 1999, vol 127, pp 1-31.
4. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E and iron status. Free Radic Biol Med 1994;16:339-346.
5. Witko-Sarstat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
6. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 1998;9:2349-2356.
7. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia? Kidney Int 1998;54:1290-1295.
8. Huysmans K, Lins RL, Daelemans R, Zachée P, De Broe ME: Hypertension and accelerated atherosclerosis in end-stage renal disease. J Nephrol 1998;11:185-195.
9. Devaraj S, Li D, Jialal I: The effects of alpha-tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin-1-beta secretion, and monocyte adhesion to endothelium. J Clin Invest 1996;98:756-763.
10. Haag-Weber M, Horl WH: Uremia and infection: Mechanisms of impaired cellular host defense. Nephron 1993;63:125-131.
11. Heidenreich S, Schmidt M, Bachmann J, Harrach B: Apoptosis of monocytes cultured from longterm hemodialysis patients. Kidney Int 1996;49:792-799.
12. Galli F, Canestrari F, Buoncristiani U: Biological effects of oxidative stress in hemodialysis. Blood Purif 1999;17:79-94.
13. Descamps-Latscha B, Heberlin A, Nguyen AT, Urena P: Respective influence of uremia and hemodialysis on whole blood phagocyte oxidative metabolism, and circulating interleukin-1 and tumor necrosis factor; in Horl WH, Schollmeyer PJ (eds): New Aspects of Human Polymorphonuclear Leukocytes. New York, Plenum Press, 1991, pp 183-192.
14. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 3. Oxford, Oxford University Press, 1999.
15. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S: The oxidation of α-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett 1993;326:199-203.
16. Chan AC: Vitamin E and atherosclerosis. J Nutr 1998;128:1593-1596.
17. Diplock AT, Chaleux JL, Crozier-Willi G, Kok FS, Rice-Evans C, Roberfroid M, Stahl W, Wiña-Ribes J: Functional food sciences and defenses against reactive oxygen species. Br J Nutr 1998;80: S77-S112.
18. Bendich A: Antioxidant vitamins and human immune responses; in Litwack G (ed): Vitamins and Hormones. San Diego, Academic Press, 1996, pp 35-62.
19. Panzetta O, Cominacci L, Garbin U, Fratta Pasini A, Gammaro L, Bianco F, Davoli A, Campagnola M, De Sancis A, Pastorino AM: Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration. Clin Nephrol 1995; 44:303-309.
20. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B, Canaud B: Erythropoietin and oxidative stress in hemodialysis. Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-2317.
21. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Covarelli C, Canestrari F: Oxidative damage during hemodialysis using a vitamin E-modified dialysis membrane: A preliminary characterization. Nephron 1997;77:57-61.
22. Galli F, Rovidati S, Chiarantini L, Kulurianu H, Canestrari F, Buoncristiani U: Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 1998;54:580-589.
23. Buocristiani U, Galli F, Benedetti S, Errico R, Beninati S, Ghibelli L, Rovidati S, Floridi A, Canestrari F: Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes; in Ronco C (ed): PMMA, a flexible membrane for a tailored dialysis. Contrib Nephrol. Basel, Karger, 1998, vol 125, pp 133-158.
24. Canestrari F, Galli F, Giorgini A, Galiotta P, Pascucci M, Bossù M: Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol 1994;91:187-193.
25. Miki M, Tamai H, Mino M, Yamamoto Y, Niki E: Free-radical chain oxidation of rat red blood cells by molecular oxygen and its inhibition by ·-tocopherol. Arch Biochem Biophys 1987;258:373-380.
26. Moeslinger T, Brunner M, Volf I, Spieckemann PG: Spectrophotometric determination of ascorbic acid and dehydroascorbic acid. Clin Chem 1995;41:1177-1181.
27. Allen RC: Phagocytic leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis. Methods Enzymol 1986;133:449-491.
28. Roselaar SE, Nazhat NB, Winyard PG, Jones P, Cunningham J, Blake DR: Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int 1995;48:199-206.
29. Hassan MQ, Hussain SA, Zaki MA, Alsharif NZ, Stohs SJ: Protective effects of antioxidants against uraemia-induced lipid peroxidation and glutathione depletion in humans. Pharmacol Toxicol 1995;77:407-411.
30. Fiorillo C, Oliviero C, Rizzuti G, Nediani C, Pacini A, Nassi P: Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis. Clin Chem Lab Med 1998;36:149-153.
31. Markert M, Wauters JP: New aspects of oxidative metabolism of neutrophils during hemodialysis on different dialyzer membranes; in Horl WH, Schollmeyer PJ (eds): New Aspects of Human Polymorphonuclear Leukocytes. New York, Plenum Press, 1991, pp 183-192.
32. Himmelfarb J, Lazarus JM, Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991;17:271-276.
33. 2 cytotoxicity pH-dependent? in Rice-Evans CA, Halliwell B (eds): Free Radicals Methodology and Concepts. London, Richelieu Press, 1988, pp 539-551.
34. Rice-Evans CA, Gopinathan V: Oxygen toxicity, free radicals and antioxidants in human disease: Biochemical implications in atherosclerosis and the problems of premature neonates; in Apps DK, Tripton KF (eds): Essays in Biochemistry. London, Portland Press, 1995, pp 39-63.
35. Costagliola C, Romano L, Scibelli G, de Vincentiis A, Sorice P, Di Benedetto A: Anemia and chronic renal failure: A therapeutical approach by reduced glutathione parenteral administration. Nephron 1992;61:404-408.
36. Usberti M, Lima G, Arisi M, Bufano G, D'Avanzo L, Gazzotti RM: Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. J Nephrol 1997;10:261-265.
37. Strain JJ, Mulholland CW: Vitamin C and vitamin E - synergistic interactions in vivo? In Emerit I, Chance B (eds): Free Radicals and Aging. Basel, Birkhäuser, 1992, pp 419-422.
38. Packer L: Interactions among antioxidants in health and disease: Vitamin E and its redox cycle. Proc Soc Exp Biol Med 1992;200:271-276.
39. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15: 7-10.
40. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam MC, King AJ, Pereira BJG: Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999;10:93-100.
41. Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulator of signal transduction. Free Radic Biol Med 1997;22:269-285.
42. Sun Y, Oberley LW: Redox regulation of transcriptional activators. Free Radic Biol Med 1996;21: 335-348.
43. Zeng L, Xia Y, Garcia GE, Hwang D, Wilson CB: Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest 1995;95:1669-1675.
44. Redanna P, Whelan J, Burgess JR, Eskew ML, Hildenbrandt G, Zarkower A, Scholz RW, Reddy CC: The role of vitamin E and selenium on arachidonic acid oxidation by way of the 5-lipoxygenase pathway. Ann NY Acad Sci 1989;570:136-145.
45. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A: Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 1998;15:243-249.
46. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, Civitareale P, Ciriolo MR: Rescue from apoptosis by inhibition of active GSH extrusion. FASEB J 1998;12:479-486.